22 June 2026 - Biotechnology company Lakewood-Amedex Biotherapeutics Inc (NASDAQ: LABT) announced on Monday that it has secured a new composition of matter patent from IP Australia covering its Bisphosphocin compounds, strengthening its global intell...
22 June 2026 - Gene therapy company Genprex Inc (NASDAQ: GNPX) disclosed on Monday that it has received a Notice of Allowance from the Canadian Intellectual Property Office for a patent covering the use of its Reqorsa gene therapy (quaratusugene ozep...
22 June 2026 - French biotech company Transgene (Euronext Paris:TNG) announced on Monday that it has initiated a randomised Phase 1 trial of TG4070, an individualised neoantigen therapeutic vaccine, in combination with nivolumab for the adjuvant trea...
22 June 2026 - Swedish research-based biopharmaceutical company BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) reported on Monday that it has entered into a research and collaboration agreement with US pharmaceutical firm Eli Lilly and Company to dev...
22 June 2026 - Belfast-based contract research organisation Fusion Antibodies plc (AIM: FAB) declared on Monday that it has received a notice of allowance from the Canadian Intellectual Property Office for patent application no. 3,115,150 covering tw...